Radiopharmaceuticals Market: Size, Share, Growth, Analysis, Key Players, Revenue, | Valuates Reports

and India Radiopharmaceuticals Market Size
The global Radiopharmaceuticals revenue was US$ 6761 million in 2022 and is forecast to a readjusted size of US$ 11660 million by 2029 with a CAGR of 8.0% during the forecast period (2023-2029).

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-39T15731/Global_and_India_Radiopharmaceuticals_Market_Report_Forecast_2023_2029

and India Radiopharmaceuticals Market
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
In India, the Radiopharmaceuticals revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
The major players in global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share about 90%. Oncology is the key application, which hold over 60% shares.
This report focuses on global and India Radiopharmaceuticals market, also covers the segmentation data of other regions in regional level and county level.
India is now the world's most populous country. According to IMF (its July update to its World Economic Outlook), India's GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Radiopharmaceuticals will continue to grow rapidly in the future.
Global Radiopharmaceuticals Scope and Market Size
Radiopharmaceuticals market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Radiopharmaceuticals market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-39T15731/Global_and_India_Radiopharmaceuticals_Market_Report_Forecast_2023_2029

Segment by Application
• Oncology
• Cardiology
• Other

Segment by Type

• Diagnostic Radioisotopes
• Therapeutic Radioisotopes

By Company
Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare, China Isotope & Radiation, Jubilant Pharma, Eli Lilly, Advanced Accelerator Applications, SIEMENS, Dongcheng, Navidea

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-39T15731/global-and-india-radiopharmaceuticals

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.